Asahi Kasei Pharma Corp. v. Actelion Ltd. Verdict: When Business Development Deals Go Wrong

Wednesday, August 31, 2011
12:00 PM - 01:00 PM Eastern Daylight Time

Morgan Lewis and Merrill DataSite invite you to an engaging discussion on what can happen when business development deals go wrong, how to spot a potential breach of license, and what to do when litigation is imminent.

Morgan Lewis Litigation partners will share their experiences from a recently won licensing case with antitrust overtones. After a three-month trial, a California state court jury ordered Actelion Ltd. to pay Asahi Kasei Pharma Corp. $550 million in damages for interrupting an Asahi licensing agreement to develop hypertension drug Fasudil.


Rollin Chippey
Partner, Morgan Lewis

Benjamin Smith
Partner, Morgan Lewis

David Yeary
Vice President, Merrill DataSite